October 28, 2013 — Radiologists at ProMedica Toledo Hospital Breast Care Center have a new tool to help evaluate breast tissue density on a mammogram. The U.S. Food and Drug Administration (FDA)-cleared VolparaDensity is a breast imaging software tool that uses complex physics and software to measure the amount of tissue within a patient’s breast. This information is used by a breast imaging radiologist to decide if additional breast screening beyond a mammogram might be necessary.
Toledo Hospital is the first hospital in Ohio to offer VolparaDensity. Robin Shermis, M.D., medical director, Toledo Hospital Breast Care Center, said the center selected VolparaDensity because it offers a consistent and standardized approach to calculating breast density when used in conjunction with the radiologist.
“We evaluated other commercially available density measurement tools, but adopted VolparaDensity because it has been proven to offer a reliable and objective volumetric measurement,” said Shermis. “Our patients can take comfort in knowing that when they come to our center, they will be thoroughly assessed and vectored to additional screening in our effort to improve the early detection of cancer.”
For more information: www.promedica.org
May 10, 2024 
